Marconato, M.; Maringer, Y.; Walz, J.S.; Nelde, A.; Heitmann, J.S.
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome. Cancers 2022, 14, 4659.
https://doi.org/10.3390/cancers14194659
AMA Style
Marconato M, Maringer Y, Walz JS, Nelde A, Heitmann JS.
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome. Cancers. 2022; 14(19):4659.
https://doi.org/10.3390/cancers14194659
Chicago/Turabian Style
Marconato, Maddalena, Yacine Maringer, Juliane S. Walz, Annika Nelde, and Jonas S. Heitmann.
2022. "Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome" Cancers 14, no. 19: 4659.
https://doi.org/10.3390/cancers14194659
APA Style
Marconato, M., Maringer, Y., Walz, J. S., Nelde, A., & Heitmann, J. S.
(2022). Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome. Cancers, 14(19), 4659.
https://doi.org/10.3390/cancers14194659